Skip to main content
. 2016 Feb 19;40(1):70–78. doi: 10.4093/dmj.2016.40.1.70

Table 4. Comparison of differences among various clinical factors between the 10 and 40 mg groups.

Factor Difference in 10 mg group Difference in 40 mg group P valuea
CPK, U/L 24.6±146.2 -9.1±48.3 0.359
AST, IU/L 1.4±5.2 0.3±10.0 0.622
ALT, IU/L 0.9±8.2 0.4±19.4 0.901
Insulin, µIU/mL -2.8±11.4 -7.3±41.2 0.599
C-peptide, pmol/mL -0.2±0.5 -0.2±0.9 0.818
HbA1c, % -0.3±1.1 -0.1±1.1 0.524
Glucose, mg/dL -4.7±90.4 -23.9±61.4 0.393
TC, mg/dL -60.9±21.6 -78.7±26.3 0.012
LDL-C, mg/dL -55.9±20.8 -71.5±24.7 0.019
HDL-C, mg/dL -1.4±7.9 0.7±7.5 0.351
TG, mg/dL -47.6±76.4 -54.4±107.8 0.794
GDF-15, pg/mL -9.5±398.7 69.7±480.0 0.527
HOMA-IR -0.9±6.0 -1.5±6.7 0.738
hsCRP, mg/dL -1.3±2.5 -1.3±2.4 0.979

Values are presented as mean±standard deviation.

CPK, creatine phosphokinase; AST, aspartate transaminase; ALT, alanine transaminase; HbA1c, glycosylated hemoglobin; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; GDF-15, growth differentiation factor 15; HOMA-IR, homeostasis model assessment-estimated insulin resistance; hsCRP, high-sensitivity C-reactive protein.

aP value determined using the Mann-Whitney U test.